Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|April 30, 2020
Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label TrialAdrian Curran, Anna Rull, Jordi Navarro, et al.
AIDS (London, England)|November 25, 2011
Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudyAdrian Curran, Esteban Martinez, Maria Saumoy, et al.
Antiviral Therapy|June 21, 2011
Low-density lipoprotein size and lipoprotein-associated phospholipase A2 in HIV-infected patients switching to abacavir or tenofovirMaria Saumoy, Jordi Ordoñez-Llanos, Esteban Martínez, et al.
The Journal of Antimicrobial Chemotherapy|September 4, 2016
Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patientsAdrian Curran, Jhon Rojas, Alfonso Cabello, et al.
Antiviral Therapy|March 1, 2012
Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO trialAdrian Curran, Esteban Martinez, Daniel Podzamczer, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2014
Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trialJosé Moltó, Marta Valle, Elena Ferrer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2015
The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trialJosé R Santos, María Saumoy, Adrian Curran, et al.
The Journal of Infectious Diseases|August 1, 2023
Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir AlafenamideSofía Scévola, Jordi Niubó, Pere Domingo, et al.
The American Journal of Tropical Medicine and Hygiene|May 1, 2013
Ultrasensitive real-time PCR for the clinical management of visceral leishmaniasis in HIV-Infected patientsIsrael Molina, Roser Fisa, Cristina Riera, et al.
JCI Insight|July 21, 2026
Granulocytic Myeloid-Derived Suppressor Cells Sustain HIV Reservoirs by Inhibiting Viral Reactivation via Arginase-1-Mediated MechanismsAna Gallego-Cortés, Judith Grau-Expósito, Irene Mota-Gómez, et al.
Pageof 8